|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 NEW YORK AVENUE, NW, #510 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Irving |
State | TX |
Zip Code | 75039 |
Country | USA |
|
5. Senate ID# 40021-00012
|
||||||||
|
6. House ID# 313240000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Michael J. Regier, Senior Vice President Legal and Corporate Affairs and General Counsel |
Date | 07/10/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Hospital Value Based Purchasing - (H.R. 1776) - supported the passage of the Quality FIRST act. Monitored and expressed concerns about hospital value based purchasing proposal included in Senate Finance Committee options paper. Monitored draft health reform legislation for inclusion of a hospital value based purchasing proposal.
Bundling of Medicare payments - Monitored efforts to include proposals to bundle Medicare payments, similar to the bundling proposal included in the Senate Finance Committee Options papers.
Witholding Medicare Reimbursement for Hospital Readmissions - Monitored efforts to include proposal to withold Medicare reimbursements for certain hospital readmissions, such as the proposal included in the Senate Finance Committee options papers.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Care Reform - (Draft legislation offered by the three House Committees of jurisdiction, the Senate Health, Education, Labor and Pensions Committee, and the Senate Finance Committee). Monitored draft language, engaged members and staff on problematic proposals that would negatively impact hospitals' ability to continue providing care, while supporting proposals that would add to the number of individuals covered by health insurance.
340b (of the Public Health Services Act) Drug Pricing - General outreach and education on the 340B program. Monitored legislation that would extend the program to inpatient drugs (S.1239, H.R.444). Followed efforts to include changes to the 340b discount drug pricing program in draft health reform legislation.
Hospital group purchasing - Monitored and advocated on potential legislative language related to hospital group purchasing organizations considered for inclusion in to-be-released health reform legislation. Worked to demonstrate the benefits that group purchasing organizations provide to hospitals through contracting as well as clinical improvement and other services.
Sunshine Act - (S. 301) - tracking and monitoring S. 301or similar legislative language for possible inclusion in to-be-released draft health reform legislative package and the potential impact for hospitals and group purchasing organizations
Health Care Information Technology - Monitored legislative proposals to expand the adoption of health care information technology. Tracked proposals that would expand privacy requirements in potential health reform efforts.
Unique Device Identification - Supported promulgation of regulations requiring unique identifiers for medical devices as required under the Food and Drug Administration Amendments Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Not-for-profit hospital tax exemption and Community Benefit Standard - Outreach to demonstrate how hospitals are fulfilling required community benefit standard to maintain tax-exemption. Opposed the inclusion of burdensome legislative language in to-be-released health reform legislation, expressed opposition to community benefit standard proposals outlined in Senate Finance Committee options paper.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Edward |
Goodman |
|
|
|
Cidette |
Perrin |
|
|
|
Steven |
Rixen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |